Celldex Therapeutics, Inc.
(NASDAQ : CLDX)

( )
CLDX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.67%463.201.0%$800.74m
ABTAbbott Laboratories 0.30%122.580.8%$584.39m
MDTMedtronic Plc 0.07%117.940.6%$576.08m
DHRDanaher Corp. -0.77%223.930.7%$516.43m
BSXBoston Scientific Corp. -0.44%38.731.0%$411.57m
ISRGIntuitive Surgical, Inc. -1.21%750.002.3%$398.60m
ALGNAlign Technology, Inc. -0.34%563.216.4%$380.46m
BDXBecton, Dickinson & Co. -0.39%245.091.0%$343.43m
SYKStryker Corp. -0.35%245.761.3%$320.80m
DXCMDexCom, Inc. -1.20%391.917.8%$307.03m
IDXXIDEXX Laboratories, Inc. -1.62%529.473.8%$276.50m
BAXBaxter International, Inc. -0.37%77.651.8%$240.63m
ZBHZimmer Biomet Holdings, Inc. -1.19%161.461.7%$226.59m
EWEdwards Lifesciences Corp. 0.57%86.260.4%$219.41m
INOInovio Pharmaceuticals, Inc. -13.62%10.024.8%$212.43m

Company Profile

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.